Biotech

All Articles

Editas cashes in on Tip Cas9 licensing liberties for $57M

.Against the backdrop of a Cas9 license battle that rejects to perish, Editas Medicine is actually c...

Ultragenyx fine-tunes gene therapy dosing to dial up efficiency

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson disease genetics therapy UX701 hav...

Biopharma cutback cost maintains in Q3: Brutal Biotech analysis

.As summer months warm relies on cool down winds, hopes that this year would certainly take wide-spr...

J &amp J loses stage 2 dengue applicant in newest change coming from vaccines

.Johnson &amp Johnson's deprioritization of its own contagious condition pipeline has actually decla...

Relay sheds 10% of staff after earlier layoffs in July

.Preciseness medication biotech Relay Therapeutics is actually losing around 10% of its own workforc...

Pentixapharm credit ratings $22M IPO to loan radiopharma trials

.Pentixapharm has produced nearly 20 million euros ($ 22 thousand) from an IPO, with the German biot...

Lundbeck water faucets Charles Waterway for AI-enabled neuro drug invention

.Lundbeck has used Charles Stream Laboratories' artificial intelligence capacities to help the disco...

Big pharma, biotech 'won't necessarily be symbiotic' in AI: S&ampP

.Large Pharma is spending intensely in AI to slash progression timelines as well as foster advanceme...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Biography has trapped $115 million in series B funds to evolve preclinical antitoxin progra...

IGM turns from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences finished last year giving up workers and enhancing its cancer cells pipeline. Curre...